CETUXIMAB VERSUS BEVACIZUMAB IN METASTATIC COLORECTAL CANCER: A COMPARATIVE EFFECTIVENESS AND PATIENT-REPORTED OUTCOMES MULTICOHORT STUDY

被引：0
|
作者：
Marques, R. P. [1 ]
Heudtlass, P. [2 ]
Godinho, A. R. [2 ]
Pais, H. L. [1 ]
Quintela, A. [1 ]
Lopes, da Cruz J. P. [1 ]
Martins, A. P. [3 ]
机构：
[1] Ctr Hosp Univ Lisboa Norte, Lisbon, Portugal
[2] Ctr Hlth Evaluat & Res, Lisbon, Portugal
[3] Univ Lisbon, Fac Pharm, Lisbon, Portugal
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN18
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [1] Cetuximab versus bevacizumab in metastatic colorectal cancer: a comparative effectiveness study
    Marques, Rui Pedro
    Godinho, Ana Rita
    Heudtlass, Peter
    Pais, Helena Luna
    Quintela, Antonio
    Martins, Ana Paula
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (05) : 1321 - 1334
  • [2] Cetuximab versus bevacizumab in metastatic colorectal cancer: a comparative effectiveness study
    Rui Pedro Marques
    Ana Rita Godinho
    Peter Heudtlass
    Helena Luna Pais
    António Quintela
    Ana Paula Martins
    [J]. Journal of Cancer Research and Clinical Oncology, 2020, 146 : 1321 - 1334
  • [3] Comparative effectiveness of bevacizumab versus cetuximab in patients with metastatic colorectal cancer
    Su, Yi-Chia
    Yang, Yea-Huei Kao
    Wu, Chih-Chien
    Su, Chien-Chou
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 103 - 103
  • [4] Patient-reported outcomes and health-related quality of life for cetuximab versus bevacizumab in metastatic colorectal cancer: a prospective cohort study
    Marques, Rui Pedro
    Heudtlass, Peter
    Pais, Helena Luna
    Quintela, Antonio
    Martins, Ana Paula
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (07) : 1719 - 1728
  • [5] Patient-reported outcomes and health-related quality of life for cetuximab versus bevacizumab in metastatic colorectal cancer: a prospective cohort study
    Rui Pedro Marques
    Peter Heudtlass
    Helena Luna Pais
    António Quintela
    Ana Paula Martins
    [J]. Journal of Cancer Research and Clinical Oncology, 2019, 145 : 1719 - 1728
  • [6] Comparative Effectiveness of Bevacizumab versus Cetuximab in Metastatic Colorectal Cancer Patients without Primary Tumor Resection
    Su, Yi-Chia
    Wu, Chih-Chien
    Su, Chien-Chou
    Hsieh, Meng-Che
    Cheng, Ching-Lan
    Kao Yang, Yea-Huei
    [J]. CANCERS, 2022, 14 (09)
  • [7] Comparative Effectiveness of Cetuximab Versus Panitumumab in Patients With Metastatic Colorectal Cancer: A Nationwide Database Study
    Wu, Chih-chien
    Su, Chien-chou
    Chen, Yu-hsun
    Hsu, Chao-wen
    Hsieh, Meng-che
    Chang, Yu-ching
    Wang, Yung-chang
    Su, Yi-chia
    [J]. ANTICANCER RESEARCH, 2023, 43 (11) : 5127 - 5138
  • [8] Cetuximab or bevacizumab in metastatic colorectal cancer?
    Sclafani, Francesco
    Cunningham, David
    [J]. LANCET ONCOLOGY, 2014, 15 (10): : 1040 - 1041
  • [9] Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal Cancer
    Advani, Shailesh M.
    Shi, Quilling
    Overman, Michael J.
    Loree, Jonathan M.
    Lam, Michael
    Morris, Van
    Shureiqi, Imad
    Kee, Bryan
    Dasari, Arvind
    Vilar, Eduardo
    Sarshekeh, Amir Mehrvarz
    Lin, Huei K.
    Manue, Shanequa
    Hamilton, Stan
    Raghav, Kanwal
    Maru, Dipen
    Kopetz, Scott
    Wang, Xin Shelley
    [J]. CLINICAL COLORECTAL CANCER, 2020, 19 (01) : 48 - +
  • [10] Comparative Effectiveness Study of Proton Therapy Versus IMRT for Definitive Treatment of Prostate Cancer Based on Patient-Reported Outcomes
    Hoppe, B. S.
    Michalski, J. M.
    Mendenhall, N. P.
    Morris, C. G.
    Henderson, R. H.
    Nichols, R. C.
    Regan, M. M.
    Sandler, H. M.
    Sanda, M. G.
    Hamstra, D. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S346 - S346
12345